Gateway Advisory, LLC Neurocrine Biosciences Inc Transaction History
Gateway Advisory, LLC
- $558 Million
- Q3 2024
A detailed history of Gateway Advisory, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gateway Advisory, LLC holds 2,856 shares of NBIX stock, worth $328,497. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,856
Previous 2,309
23.69%
Holding current value
$328,497
Previous $317,000
3.47%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
96.2MCall Options Held
380KPut Options Held
382K-
Black Rock Inc. New York, NY14.2MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$563 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$347 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$292 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...